{"id":2402,"date":"2020-11-25T09:27:51","date_gmt":"2020-11-25T17:27:51","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=2402"},"modified":"2020-11-30T09:29:06","modified_gmt":"2020-11-30T17:29:06","slug":"estimated-sars-cov-2-seroprevalence-in-the-us-as-of-september-2020","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/11\/25\/estimated-sars-cov-2-seroprevalence-in-the-us-as-of-september-2020\/","title":{"rendered":"Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020"},"content":{"rendered":"<ul>\n<li>A repeated cross-sectional study carried out in all 50 US states, the District of Columbia, and Puerto Rico found that although SARS-CoV-2 seroprevalence varied between 1% and 23%, fewer than 10% of people nationally had detectable antibodies. A total of 177,919 samples were obtained during four periods between July 27 and September 24, 2020 from people presenting to a healthcare setting for routine screening or clinical care. As of the final collection of samples, the seroprevalence in Washington State was estimated to be under 5%.<\/li>\n<\/ul>\n<p>Bajema et al. (Nov 2020). Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020. JAMA Internal Medicine. <a href=\"https:\/\/doi.org\/10.1001\/jamainternmed.2020.7976\">https:\/\/doi.org\/10.1001\/jamainternmed.2020.7976<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A repeated cross-sectional study carried out in all 50 US states, the District of Columbia, and Puerto Rico found that although SARS-CoV-2 seroprevalence varied between 1% and 23%, fewer than 10% of people nationally had detectable antibodies. A total of 177,919 samples were obtained during four periods between July 27 and September 24, 2020 from&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/11\/25\/estimated-sars-cov-2-seroprevalence-in-the-us-as-of-september-2020\/\">Read more<\/a><\/div>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[32],"topic":[31],"class_list":["post-2402","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-immunity","topic-vaccines-and-immunity"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/2402","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=2402"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/2402\/revisions"}],"predecessor-version":[{"id":2403,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/2402\/revisions\/2403"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=2402"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=2402"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=2402"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=2402"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}